Skip to main content
Clinical Trials/ISRCTN48911177
ISRCTN48911177
Completed
Not Applicable

Autologous Chondrocyte Transplantation/Implantation Versus Existing treatments: a randomised controlled trial

Keele University (UK)0 sites400 target enrollmentMay 18, 2001

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Keele University (UK)
Enrollment
400
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 18, 2001
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional

Investigators

Sponsor
Keele University (UK)

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 09/11/2012:
  • 1\. Symptomatic chondral defect(s) on the medical or lateral femoral condyle, trochlea or patella suitable for either ACT or one of the existing conventional treatments (debridement, abrasion, drilling, microfracture, mosaicplasty)
  • 2\. Surgical treatment for the same defect carried out at least 12 months previously, that has not relieved symptoms
  • 3\. Not more than two defects, not kissing and total area not greater than 12cm2
  • 4\. Likely to comply with appropriate physiotherapy
  • Previous inclusion criteria until 09/11/2012:
  • 1\. Symptomatic chondral defect(s) on the medical or lateral femoral condyle or trochlea suitable for either ACT or one of the existing conventional treatments (debridement, abrasion, drilling, microfracture, mosaicplasty)
  • 2\. Surgical treatment for the same defect carried out at least 12 months previously, that has not relieved symptoms
  • 3\. Not more than two defects, not kissing and total area not greater than 12cm2
  • 4\. Likely to comply with appropriate physiotherapy

Exclusion Criteria

  • 1\. Concurrent meniscectomy/osteotomy or untreated malalignment of patella
  • 2\. Generalised osteoarthritis, inflammatory condition or history of mesenchymal tumors
  • 3\. Patient in different clinical trial involving the knee, currently or in last 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials